Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2022-05-30
2022-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Analysis of Neuromuscular, Circulatory and Biomechanical Responses After Cryotherapy
NCT01872091
Analysis of the Effects on Human Tissues After Application of Therapeutic Modalities.
NCT03414346
Acute Effects of Cryotherapy on Muscle Properties
NCT06608836
Different Cryotherapy Techniques for Skin Surface Temperature, Agility and Balance of Active Youth
NCT03659474
Effect of Two Methods for the Application of Cryotherapy
NCT03707327
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cryotherapy
20 minutes of cryotherapy on the dominant ankle with ice bags
Cryotherapy
20 minutes of cryotherapy on the dominant ankle with ice bags
Control
20 minutes of rest
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cryotherapy
20 minutes of cryotherapy on the dominant ankle with ice bags
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* healthy
* no musculoskeletal complaints
Exclusion Criteria
* complaints of injury or pain during the assessments
18 Years
28 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
São Paulo State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Flávia Carvalho
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carlos M Pastre, PhD
Role: STUDY_DIRECTOR
São Paulo State University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EC003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.